According to Zhang and colleagues (2018), miR-202 is downregulated in human prostate cancer tissues and cell lines, while overexpression of miR-202 significantly suppressed prostate cancer progression, demonstrating miR-202 as a tumor suppressor via direct targeting of PIK3CA [63]. This evidence concerns the gene PIK3CA and prostate carcinoma.